Research Site

Hradec

1 studies enrolling now · 2 studies all time

What they study most

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

Studies at this site

• Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma — Recruiting now
• This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. — Completed